Remove Peripheral Arterial Disease Remove Plaque Remove Technology
article thumbnail

Philips Enrolls First Patient in Clinical Trial for Integrated Single-Device to Treat PAD

DAIC

The care team there successfully treated a 78-year-old male with peripheral vascular disease using the Philips device. Developing and driving clinical evidence is crucial to improving care and guiding the adoption of new technologies like the Philips laser atherectomy and lithotripsy system,” said Drs.

article thumbnail

HonorHealth Research Institute First in Southwest to Implant New Stroke Prevention Stent

DAIC

The Neuroguard Integrated Embolic Protection (IEP) system is an experimental treatment for carotid artery stenosis, also known as carotid artery disease, a condition in which fatty-waxy deposits known as plaque builds up and blocks the normal flow of blood in the large arteries on either side of the neck.

Stents 111
article thumbnail

Elixir Medical Granted FDA Breakthrough Device Designation for DynamX Bioadaptor

DAIC

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 1 To date, interventional treatment of coronary artery disease with drug-eluting stents has been able to establish flow angiographically. of the U.S.

article thumbnail

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

DAIC

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years. Journal of Vascular Surgery, Mar.

article thumbnail

Two Studies Show Clot-Sensing Guidewire Successfully Identifies 'Fresh Clot' to Support Decision-Making in PAD Treatment

DAIC

13, 2024Sensome hasannounced positive results from two studies of its Clotild Smart Guidewire System demonstrating its ability to successfully identify fresh clot thrombus rich in red blood cells (RBCs) in peripheral artery disease (PAD) and differentiate it from other tissue encountered during PAD procedures.